Selected article for: "acute respiratory syndrome and administration vaccine"

Author: Badyal, Dinesh Kumar; Mahajan, Rajiv
Title: Chloroquine: Can it be a Novel Drug for COVID-19
  • Cord-id: fxqseibh
  • Document date: 2020_4_2
  • ID: fxqseibh
    Snippet: Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the India
    Document: Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.

    Search related documents:
    Co phrase search for related documents
    • loading day dose and lopinavir ritonavir: 1, 2, 3
    Co phrase search for related documents, hyperlinks ordered by date